Fresenius reported EUR255M in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Akzo Nobel AKZA:NA EUR 8M 76M
Alcon AG ALC:SW USD -97000000 213M
AstraZeneca AZN:LN USD 901M 739M
BASF BAS:GR EUR -4847000000 5.76B
Bayer BAYN:GR EUR 611M 65M
Davita Healthcare Partners DVA:US USD 68.1M 37.26M
E.ON EOAN:GR EUR -1983000000 3.54B
Essilor EI:FP EUR 980M 193M
Fresenius FRE:GR EUR 255M 67M
Fresenius Medical Care FME:GR EUR 138.8M 91.3M
Fresenius Medical Care FMS:US EUR 138.8M 91.3M
Getinge GETIB:SS SEK 556M 242M
Givaudan GIVN:VX CHF 416M 24M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
GN Store Nord GN:DC DKK 263M 66M
Hikma Pharmaceutical HIK:LN USD 15M 158M
Lonza Group LONN:SW CHF 723M 231M
Merck MRK:GR EUR 654M 269M
Novartis NOVN:VX USD 1.47B 107M
Philips PHIA:NA EUR -105000000 1.22B
Roche Holding ROG:VX 3.89B 4.64B
Smith & Nephew PLC SN/:LN 177M 142M
William Demant Holding WDH:DC DKK 1.03B 16M